e-learning
resources
ERJ
2007
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Transgenic and gene-targeted mice as models for chronic obstructive pulmonary disease
Shapiro S. D.
Source:
Eur Respir J 2007; 29: 375-378
Journal Issue:
February
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Shapiro S. D.. Transgenic and gene-targeted mice as models for chronic obstructive pulmonary disease. Eur Respir J 2007; 29: 375-378
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
SEWQ ZAV - 20.09.2021 12:32
I have recently been told I have COPD/emphysema due to smoking. A few years back my general physician said there was something showing on my lungs. Thanks To World Herbs Clinic, Their Emphysema/COPD herbal supplement is nothing less than a miracle, I am fully back on my feet again and strong!.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Implication of microRNA-148b in chronic obstructive lung disease of betaENaC-overexpressing mice
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013
Cigarette smoke induced pulmonary emphysema is attenuated in CCR6 deficient mice
Source: Annual Congress 2006 - Cell biology of asthma and COPD
Year: 2006
Elastin expression in very severe human COPD
Source: Eur Respir J 2009; 33: 324-331
Year: 2009
Chronic low-grade systemic inflammation causes DNA damage in the lungs of mice
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013
Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation
Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Year: 2006
TNF and LTA genes and susceptibility to chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 305s
Year: 2004
Model of staged development chronic obstructive pulmonary disease (COPD) in rats
Source: Annual Congress 2011 - Novel mechanisms in lung injury
Year: 2011
Longterm NO2-exposure induces pulmonary inflammation and progressive development of airflow obstruction in C57BL/6 mice
Source: Eur Respir J 2003; 22: Suppl. 45, 196s
Year: 2003
Screening for α1-Pi deficiency in patients with lung diseases
Source: Eur Respir J 2002; 20: 319-324
Year: 2002
Serum and skeletal muscle leptin in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2005 - Systemic effects of COPD
Year: 2005
Laboratory testing of individuals with severe α1-antitrypsin deficiency in three European centres
Source: Eur Respir J 2010; 35: 960-968
Year: 2010
Enhanced expression of IL-18 receptor but not soluble form of IL18R in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - COPD: clinical studies and animal cell models
Year: 2011
Inferon administration to patients with chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation
Year: 2009
Nintedanib has acute pulmonary vasodilatory effects in transgenic Fra2 mice with spontaneous progressive pulmonary hypertension and lung fibrosis.
Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2019
Functional single nucleotide polymorphisms of the CCL5 gene and nonemphysematous phenotype in COPD patients
Source: Eur Respir J 2008; 32: 372-378
Year: 2008
Desmosin as a marker for tissue injury in COPD
Source: Annual Congress 2007 - α
1
-Antitrypsin deficiency: molecular and clinical news
Year: 2007
Interleukin-18 production and pulmonary function in COPD
Source: Eur Respir J 2008; 31: 287-297
Year: 2008
Circulating tumor cells in chronic obstructive pulmonary disease patients
Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer
Year: 2011
Chronic lung disease in CF mouse models, role of macrophages, treatment with azithromycin
Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease
Year: 2009
A transient receptor potential melastin-2 deficiency significantly worsens the fibrotic response to bleomycin in mice
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept